Reduced levels of ZIP4 inhibit the growth of pancreatic cancer cells by decreasing cyclin D1, a target of the cAMP-response element binding protein (CREB)/miR-373/PHLPP2 and CREB/IL-6/STAT3 pathways 66, 81. Here, STAT3 is linked to pancreatic neoplasm.